Neogen Chemicals to Discuss Q1FY27 Results on July 27 at 4 PM IST

1 min read     Updated on 20 Jul 2026, 10:59 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Neogen Chemicals Limited has scheduled a Q1FY27 earnings conference call on July 27, 2026, at 4:00 PM IST, where senior management will discuss financial results and host a Q&A session for analysts and investors. The company, a manufacturer of Bromine-based and Lithium-based specialty chemicals with four facilities in Maharashtra and Gujarat, has provided universal and regional toll-free dial-in numbers for global participant accessibility.

powered bylight_fuzz_icon
46093358

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited will host an earnings conference call on July 27, 2026, at 4:00 PM IST to discuss its financial performance for the first quarter of FY27. The session aims to provide analysts and investors with insights into the company's operational results and strategic outlook. No unpublished price sensitive information will be shared during the call.

The event will commence with a brief management discussion on the Q1FY27 results, followed by an interactive question-and-answer session. Senior members of the management team will represent the company during the proceedings. The intimation was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Participants are required to pre-register to receive dial-in numbers, a passcode, and a PIN. The registration link is available to facilitate a connection without waiting for an operator. The company has provided universal and toll-free dial-in numbers for various regions to ensure accessibility for global stakeholders.

Dial-in Details

Parameter: Details
Timing 4:00 PM IST on Monday, July 27, 2026
Universal Dial-in +91 22 6280 1141 / 7115 8042
Hong Kong Toll Free 800 964 448
Singapore Toll Free 800 101 2045
UK Toll Free 0 808 101 1573
USA Toll Free 1 866 746 2133

Neogen Chemicals is a manufacturer of Bromine-based and Lithium-based specialty chemicals. The company operates four manufacturing facilities located in Maharashtra and Gujarat. In January 2025, Buli Chemicals India Private Limited, a wholly owned subsidiary, was merged with the company.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%-11.14%+6.78%+82.27%+32.06%+131.23%

How will the recent merger with Buli Chemicals India Private Limited impact Neogen's revenue growth and operational efficiency in FY27?

What are the management's expectations for the demand outlook of Lithium-based specialty chemicals given the evolving electric vehicle market dynamics?

Are there any planned capacity expansions or new product launches in the Bromine and Lithium segments for the upcoming fiscal year?

Neogen Chemicals receives Rs 15 Cr insurance claim for Dahej fire

1 min read     Updated on 20 Jul 2026, 03:43 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Neogen Chemicals received Rs 15 Cr on July 16, 2026, as the fourth on-account payment for the Dahej fire, bringing total claims to Rs 155 Cr. The company recognized a net loss of Rs 13.56 Cr in FY 2024-25 against a total assessed loss of Rs 348.16 Cr.

powered bylight_fuzz_icon
45832529

*this image is generated using AI for illustrative purposes only.

Neogen Chemicals Limited has received an additional amount of Rs 15 Cr towards the fourth on-account payment for the fire incident that occurred at its Dahej SEZ facility. The payment, received on July 16, 2026, covers loss of property, plant, and equipment based on surveyors' recommendations. The total on-account claim received to date stands at Rs 155 Cr, including this latest tranche.

The fire, which took place on March 5, 2025, affected the Multi-Purpose Plant (MPP3)- Facility, warehouse, and tank farms. The company has recognized a net loss of Rs 13.56 Cr (Rs 14.08 Cr on a consolidated basis) in FY 2024-25 after accounting for the damage and insurance receivables. The total assessed loss was Rs 348.16 Cr, against which the company recognized an insurance claim receivable of Rs 334.60 Cr.

Further settlement of claims will be determined in stages following the completion of the assessment for loss of assets, loss of profit due to business interruption, and reinstatement value. The company has not accounted for claims regarding loss of profit and excess reinstatement value over written down value, adhering to accounting conservatism.

Financial Impact and Salvage

The company has realized Rs 9.38 Cr from the sale of salvaged scrap and incurred incidental charges of Rs 1.41 Cr, which have been claimed under the insurance policy. The table below details the financial figures reported in the filing.

Metric Standalone Amount Consolidated Amount
Loss recognized Rs 348.16 Cr Rs 362.90 Cr
Insurance claim receivable Rs 334.60 Cr Rs 348.82 Cr
Net loss considered Rs 13.56 Cr Rs 14.08 Cr
Salvaged scrap sold Rs 9.38 Cr Rs 9.38 Cr
Incidental charges incurred Rs 1.41 Cr Rs 1.41 Cr

Operational Status

Production and operations at the affected MPP3 facility remain temporarily suspended. Construction of the replacement plant is progressing rapidly, with commissioning scheduled for H1FY27. To mitigate business disruption, the company has shifted the production of critical select specialty products to other sites with customer approval and is proceeding with a planned expansion at its Patancheru Plant.

Historical Stock Returns for Neogen Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-1.16%-11.14%+6.78%+82.27%+32.06%+131.23%

What is the expected timeline for receiving the remaining insurance claims related to loss of profit and reinstatement value?

How will the temporary suspension of MPP3 and the shift in production impact Neogen's profit margins in H1FY27?

What capital expenditures are required for the new Patancheru expansion, and how will it be funded?

More News on Neogen Chemicals

1 Year Returns:+32.06%